<50 kg: 100 mg q6h or 200 mg q12h (controlled release)

>50 kg: 150 mg q6h or 300 mg q12h (controlled release); if no response, may increase to 200 mg q6h; maximum dose required for patients with severe refractory ventricular tachycardia is 400 mg q6h.